GlassScriptPhysician profile
Vanessa Orta Aaronson
NPI 1407962749
$1,673.11
in general payments reported to CMS, 2019-2025
12 companies · $90.51 in 2025
The $90.51 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $289 · 2021: $166 · 2022: $307 · 2023: $483 · 2024: $337 · 2025: $90.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $911.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $911.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $237.24 | 2019-2024 | Hydrus Microstent |
| Johnson & Johnson Vision Care, INC. | $213.42 | 2023-2024 | Acuvue |
| Dompe US, INC. | $210.37 | 2022-2023 | Oxervate |
| Bausch & Lomb Americas INC. | $206.51 | 2023-2025 | Infuse, Vyzulta |
| Horizon Therapeutics Plc | $200.39 | 2022-2023 | Tepezza |
| Kala Pharmaceuticals, INC. | $150.15 | 2021 | |
| Shire North American Group INC | $129.03 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $114.75 | 2024 | Xdemvy |
| Allergan, INC. | $98.00 | 2022 | |
| Abb Con-Cise Optical Group LLC | $66.96 | 2019 | |
| Oyster Point Pharma, INC. | $30.79 | 2022 | |
| Novartis Pharmaceuticals Corporation | $15.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vanessa Aaronson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.